Viking Therapeutics, Inc. (VKTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

$42.35

north_east $0.03 (0.07%)
Day's range
$41.61
Day's range
$42.91

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/02/2024 Piper Sandler Biren Amin $74.00 $52.94   39.78%
11/04/2024 Laidlaw Yale Jen $110.00 $63.14   74.22%
11/04/2024 Jefferies Roger Song $110.00 $63.14   74.22%
06/27/2024 Morgan Stanley Michael Ulz $105.00 $47.39   121.57%
06/25/2024 H.C. Wainwright Joseph Pantginis $90.00 $52.12   72.68%
05/16/2024 Raymond James Steve Seedhouse $116.00 $69.06   67.97%
05/16/2024 Truist Financial Joon Lee $120.00 $69.53   72.6%
03/26/2024 Oppenheimer Jay Olson $138.00 $80.83   70.73%
03/26/2024 BTIG Justin Zelin $125.00 $83.98   48.84%
03/26/2024 Stifel Nicolaus Samimy Annabel $95.00 $83.87   13.27%
03/15/2024 BTIG Justin Zelin $100.00 $62.56   59.85%
No analyst forecast available for this stock.

Viking Therapeutics, Inc. FAQ's

What analysts cover Viking Therapeutics, Inc.?

Viking Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Laidlaw, Jefferies, Morgan Stanley, H.C. Wainwright, Raymond James in the past 90 days.